Literature DB >> 10553096

Substance P activates coincident NF-AT- and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization.

K L Quinlan1, S M Naik, G Cannon, C A Armstrong, N W Bunnett, J C Ansel, S W Caughman.   

Abstract

Upon stimulation, cutaneous sensory nerves release neuropeptides such as substance P (SP), which modulate responses in the skin by activating a number of target cells via neurokinin receptors. We have demonstrated that SP preferentially binds to the NK-1R on human dermal microvascular cells, resulting in increased intracellular Ca2+ and induction of ICAM-1 and VCAM-1 expression. In the current studies, we identify specific elements in the regulatory regions of ICAM-1 and VCAM-1 genes as necessary and sufficient for SP-dependent transcriptional activation. SP treatment of human dermal microvascular endothelial cells leads to coincident activation and binding of the transcription factor NF-AT to the -191/-170 region of the ICAM-1 gene (a region bound by activated p65/p65 homodimers in response to TNF-alpha), and NF-kappa B (p65/p50) to tandem NF-kappa B binding sites at -76/-52 of the VCAM-1 gene. The SP-elicited intracellular Ca2+ signal was required for activation and subsequent binding of both NF-AT and NF-kappa B. The transacting factor induction by SP was specific, since a selective NK-1R antagonist blocked SP activation and subsequent NF-AT and NF-kappa B activation and binding. These data demonstrate coincident activation of NF-AT and NF-kappa B via SP-induced intracellular Ca2+ mobilization and indicate a crucial role for neuropeptides in modulating localized cutaneous inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553096

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.

Authors:  J P Lai; W Z Ho; G X Zhan; Y Yi; R G Collman; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  A substance P antagonist improves outcome in female Sprague Dawley rats following diffuse traumatic brain injury.

Authors:  Frances Corrigan; Anna Leonard; Mounir Ghabriel; Corinna Van Den Heuvel; Robert Vink
Journal:  CNS Neurosci Ther       Date:  2012-06       Impact factor: 5.243

Review 3.  Role of endoplasmic reticulum stress in cystic fibrosis-related airway inflammatory responses.

Authors:  Carla M P Ribeiro; Richard C Boucher
Journal:  Proc Am Thorac Soc       Date:  2010-11

4.  Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells.

Authors:  Margherita Gallicchio; Arianna Carolina Rosa; Elisa Benetti; Massimo Collino; Chiara Dianzani; Roberto Fantozzi
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

Review 5.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

6.  STAT-6-mediated control of P-selectin by substance P and interleukin-4 in human dermal endothelial cells.

Authors:  Yasuhiro Miyazaki; Takahiro Satoh; Kiyoshi Nishioka; Hiroo Yokozeki
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

7.  Adaptive plasticity in tachykinin and tachykinin receptor expression after focal cerebral ischemia is differentially linked to gabaergic and glutamatergic cerebrocortical circuits and cerebrovenular endothelium.

Authors:  R Stumm; C Culmsee; M K Schafer; J Krieglstein; E Weihe
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

Review 8.  Inflammation in acute CNS injury: a focus on the role of substance P.

Authors:  F Corrigan; R Vink; R J Turner
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

9.  Tumor necrosis factor (TNF)-alpha persistently activates nuclear factor-kappaB signaling through the type 2 TNF receptor in chromaffin cells: implications for long-term regulation of neuropeptide gene expression in inflammation.

Authors:  Djida Ait-Ali; Valérie Turquier; Yannick Tanguy; Erwan Thouënnon; Hafida Ghzili; Lourdes Mounien; Céline Derambure; Sylvie Jégou; Jean-Philippe Salier; Hubert Vaudry; Lee E Eiden; Youssef Anouar
Journal:  Endocrinology       Date:  2008-02-21       Impact factor: 4.736

10.  NF-kappaB regulates thrombin-induced ICAM-1 gene expression in cooperation with NFAT by binding to the intronic NF-kappaB site in the ICAM-1 gene.

Authors:  Jiaping Xue; Prabhakar B Thippegowda; Guochang Hu; Kurt Bachmaier; John W Christman; Asrar B Malik; Chinnaswamy Tiruppathi
Journal:  Physiol Genomics       Date:  2009-04-07       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.